| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |